Van Andel Institute joins the MetaMiner oncology partnership program

March 31, 2009

By hammersmith

[Source: PRNewswire] –  GeneGo, Inc., the leading systems biology tools company, announced today that Craig Webb, Ph.D., director of the Program of Translational Medicine at Grand Rapids, Mich.-based Van Andel Institute, has joined the MetaMiner Oncology Partnership Program.

 

The goal of the program is to develop a proprietary oncology pathway analysis platform built by experts in the field. This includes developing a series of blueprint pathway maps for cancers, collecting public domain experimental data and normalizing, parsing and making it available for use, as well as developing cancer specific ontologies.

For more information click here.